AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) General Information

Description

The commercial rights to Arimidex (anastrozole) and Casodex (bicalutamide) in various European and African countries.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Cambridge
  • England, United Kingdom
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Corporate Office
  • Cambridge
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries)‘s full profile, request access.

Request a free trial

AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries)‘s full profile, request access.

Request a free trial

AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) FAQs

  • Where is AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) headquartered?

    AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) is headquartered in Cambridge, United Kingdom.

  • What industry is AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) in?

    AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries)’s primary industry is Buildings and Property.

  • Is AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) a private or public company?

    AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) is a Private company.

  • What is the current valuation of AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries)?

    The current valuation of AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) is .

  • What is AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries)’s current revenue?

    The current revenue for AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) is .

  • Who are AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries)’s investors?

    AstraZeneca has invested in AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries).

  • When was AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) acquired?

    AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) was acquired on 20-Dec-2019.

  • Who acquired AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries)?

    AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) was acquired by Juvise Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process